Computational, Synthetic, Biochemical and Biological Studies and Characterization on STAT3 Inhibitors for Potential Anticancer Therapy

Computational, Synthetic, Biochemical and Biological Studies and Characterization on STAT3 Inhibitors for Potential Anticancer Therapy

Bibliographic Details
Main Author:	Yu, Wenying
Language:	English
Published:	The Ohio State University / OhioLINK 2013
Subjects:	Pharmacy Sciences STAT3 Anti-cancer therapy In silico site-directed FBDD MLSD
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1373328058

Similar Items

In silico and in vitro analysis reveal multi-target anti-hyperglycaemic properties of gedunin, a limonoid from neem (Azadirachta indica)
by: Suchismita Mazumdar, et al.
Published: (2020-05-01)

Coded Non-Ideal OFDM Systems: Analysis and Receiver Designs
by: Peng, Fei
Published: (2007)

The Discovery of Aurora Kinase Inhibitor by Multi-Docking-Based Virtual Screening
by: Jun-Tae Kim, et al.
Published: (2014-11-01)

An NMR-Guided Screening Method for Selective Fragment Docking and Synthesis of a Warhead Inhibitor
by: Ram B. Khattri, et al.
Published: (2016-07-01)

Fragment-Based Structural Optimization of a Natural Product Itampolin A as a p38α Inhibitor for Lung Cancer
by: Jing-wei Liang, et al.
Published: (2019-01-01)

Small Molecule Inhibitors asAnticancer Agents
by: Bhasin, Deepak
Published: (2011)

Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs
by: Martyna Plens-Galaska, et al.
Published: (2018-09-01)

Ligand selectivity: binding at the protein-protein interface of Keap1 and NEMO
by: Lynch, Andrew John
Published: (2016)

Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development
by: Jacopo Sgrignani, et al.
Published: (2018-05-01)

Carbazole Derivatives as STAT Inhibitors: An Overview
by: Anna Caruso, et al.
Published: (2021-07-01)

Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
by: David S. Lee, et al.
Published: (2018-05-01)

Identifying Ortholog Selective Fragment Molecules for Bacterial Glutaredoxins by NMR and Affinity Enhancement by Modification with an Acrylamide Warhead
by: Ram B. Khattri, et al.
Published: (2019-12-01)

The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy
by: Manlio Tolomeo, et al.
Published: (2021-01-01)

Multiple Ligand Simultaneous Docking (MLSD) and Its Applications to Fragment Based Drug Design and Drug Repositioning
by: Li, Huameng
Published: (2012)

2-Thiopyrimidine/chalcone hybrids: design, synthesis, ADMET prediction, and anticancer evaluation as STAT3/STAT5a inhibitors
by: Phoebe F. Lamie, et al.
Published: (2020-01-01)

Design, synthesis and biological evaluation of Novel Curcumin Analogs with anticipated anticancer activity
by: Iten M. Fawzy, et al.
Published: (2015-06-01)

In silico analysis of CpG islands and miRNAs potentially regulating the JAK-STAT signalling pathway
by: Beniamin O. Grabarek, et al.
Published: (2020-09-01)

Binding mode information improves fragment docking
by: Célien Jacquemard, et al.
Published: (2019-03-01)

A fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis
by: Pooja Gupta, et al.
Published: (2021-01-01)

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
by: Jennifer E. Kim, et al.
Published: (2014-02-01)

Phosphorylated Forms of STAT1, STAT3 and STAT5 Are Expressed in Proliferating but Not Involuted Infantile Hemangioma
by: Lucy Sulzberger, et al.
Published: (2018-04-01)

Small Molecule Inhibitors of Stat3 Protein as Cancer Therapeutic Agents
by: Page, Brent
Published: (2013)

Small Molecule Inhibitors of Stat3 Protein as Cancer Therapeutic Agents
by: Page, Brent
Published: (2013)

Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
by: Couto Jason I, et al.
Published: (2012-12-01)

The commercially available STAT3 inhibitor 5,15-diphenylporphyrin (5,15-DPP) does not directly interact with STAT3 core residues 127–722
by: Siphokazi Sinethemba Mtwebana, et al.
Published: (2020-07-01)

Development of Inhibitors in the IL-6/GP130/JAK/STAT Pathway as Therapeutic Agents
by: Etter, Jonathan Parker
Published: (2013)

Prediction of Positions of Active Compounds Makes It Possible To Increase Activity in Fragment-Based Drug Development
by: Yoshifumi Fukunishi
Published: (2011-05-01)

Etude et modulation des interactions protéine-protéine : l’activation de la petite protéine G Arf1 par son facteur d’échange Arno
by: Rouhana, Jad
Published: (2013)

JAK-STAT in Early Hematopoiesis and Leukemia
by: Eirini Sofia Fasouli, et al.
Published: (2021-05-01)

Impact of sex and pathophysiology on optimal drug choice in hypertensive rats: Quantitative insights for precision medicine
by: Sameed Ahmed, et al.
Published: (2021-04-01)

Redox Regulation of STAT1 and STAT3 Signaling
by: Elena Butturini, et al.
Published: (2020-09-01)

Characterization of isolated compounds from Morus spp. and their biological activity as anticancer molecules
by: Aditya Rao Rao Shimoga Janakirama, et al.
Published: (2021-05-01)

STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy
by: Sruthi V. Hindupur, et al.
Published: (2020-02-01)

Quinoline based furanones and their nitrogen analogues: Docking, synthesis and biological evaluation
by: Sukhbir Lal Khokra, et al.
Published: (2016-11-01)

Schistosoma egg antigens suppress LPS-induced inflammation in human IMR-90 cells by modulation of JAK/STAT1 signaling
by: Kang-Yun Lee, et al.
Published: (2021-06-01)

Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery
by: Jin-Young Lee, et al.
Published: (2015-08-01)

Computational Design, Synthesis and Evaluation of Novel Specific IL-6/gp130 Inhibitors as Potential Anticancer Agents
by: Mao, Liguang
Published: (2017)

Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients
by: Taheri M, et al.
Published: (2018-12-01)

Regulation of STAT6, STAT3 and STAT1 by the Cytoplasmic Tail of Polycystin-1, the Protein Affected in Polycystic Kidney Disease
by: Shivakumar, Vasanth
Published: (2007)

Conception, synthèse et dévelopement d'inhibiteurs du répresseur transcriptionnel mycobactérien ETHR selon une approche par fragments. Une nouvelle approche dans la lutte contre la tuberculose
by: Villemagne, Baptiste
Published: (2012)